Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.
Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market
Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.